<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IHC &#8211; Karkinos Healthcare</title>
	<atom:link href="https://www.karkinos.in/tag/ihc/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.karkinos.in</link>
	<description>A technology-led, purpose driven oncology platform, enabling discovery through delivery of care</description>
	<lastBuildDate>Mon, 01 Jun 2026 06:43:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.karkinos.in/wp-content/uploads/2021/03/Transparent-Favicon.png</url>
	<title>IHC &#8211; Karkinos Healthcare</title>
	<link>https://www.karkinos.in</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>HER2 and its strong link to aggressive breast cancer</title>
		<link>https://www.karkinos.in/k-vani/her2-and-its-strong-link-to-aggressive-breast-cancer/</link>
		
		<dc:creator><![CDATA[Anusha Ashwin]]></dc:creator>
		<pubDate>Mon, 18 May 2026 08:12:50 +0000</pubDate>
				<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[cancer diagnostics]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[gene sequencing]]></category>
		<category><![CDATA[genetic]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[IHC]]></category>
		<category><![CDATA[tumour]]></category>
		<guid isPermaLink="false">https://www.karkinos.in/k-vani//</guid>

					<description><![CDATA[HER2 is a molecule that significantly influences the behaviour of certain types of breast cancer. Understanding HER2 helps explain why some tumours grow rapidly and exhibit aggressive characteristics.]]></description>
		
		
		
			</item>
		<item>
		<title>What is hormone receptor testing, and why is it important for making treatment decisions?</title>
		<link>https://www.karkinos.in/k-vani/what-is-hormone-receptor-testing-and-why-is-it-important-for-making-treatment-decisions/</link>
		
		<dc:creator><![CDATA[Anusha Ashwin]]></dc:creator>
		<pubDate>Thu, 07 May 2026 07:09:13 +0000</pubDate>
				<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[cell]]></category>
		<category><![CDATA[cell division]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[ER positive breast cancer]]></category>
		<category><![CDATA[estrogen]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[hormone]]></category>
		<category><![CDATA[hormone receptor testing]]></category>
		<category><![CDATA[IHC]]></category>
		<category><![CDATA[pathologist]]></category>
		<category><![CDATA[pathology]]></category>
		<category><![CDATA[PR]]></category>
		<category><![CDATA[progesterone]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[signalling]]></category>
		<category><![CDATA[tumour]]></category>
		<guid isPermaLink="false">https://www.karkinos.in/k-vani//</guid>

					<description><![CDATA[Hormone receptor testing determines whether breast cancer cells express Estrogen Receptor and Progesterone Receptor, helping identify tumors that depend on hormonal signaling for growth. This information is critical as it plays a central role in guiding treatment decisions and prognosis.]]></description>
		
		
		
			</item>
	</channel>
</rss>
